Influence of Corneal Biomechanical Properties on Myopia Control

NCT05090592 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-10-25

No results posted yet for this study

Summary

to analyze the changes in corneal biomechanics of myopic children with different treatment (low concentration atropine eye drops and orthokeratology) and explore the possible mechanism of myopia control

Conditions

  • Myopia

Interventions

DEVICE

orthokeratology

orthokeratology wearing for myopia control

DRUG

0.01 atropine

0.01% atropine eye drop prevent myopic progression

Sponsors & Collaborators

  • Buddhist Tzu Chi General Hospital

    lead OTHER

Principal Investigators

  • Cheng-Jen Chiu, Doctor · Tzu Chi genral hospital

Eligibility

Min Age
8 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-07-30
Completion
2022-12-31
FDA Drug
Yes
FDA Device
Yes

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090592 on ClinicalTrials.gov